GPT Healthcare Q2 FY27 Results (NSE: GPTHEALTH)
Signal: Margin expansion
The read
The trajectory is improving for a second consecutive quarter: Q2 total income reached ₹138.6 crore, up 15.2% YoY and 8.1% QoQ, while EBITDA margin rose to 21.5% from 20.0% YoY and network occupancy improved to 50.3%; ARPOB growth of 7.1% to ₹40,721 adds a mix and realisation tailwind, with Jamshedpur still scheduled for Q4 FY27 completion.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹138.6 Cr | 15.2% | 8.1% |
| Net profit | ₹15.4 Cr | 45.2% | |
| EBIT margin | 21.5% |
P&L walk
Q2 total income of ₹138.6 crore grew 15.2% YoY and 8.1% QoQ, while EBITDA of ₹29.8 crore grew 23.9% YoY and 13.8% QoQ; margin expansion to 21.5% and PAT growth to ₹15.4 crore indicate improving utilisation and contribution from mature hospitals.
Key positives
- EBITDA grew 23.9% YoY to ₹29.8 crore versus 15.2% total-income growth to ₹138.6 crore, lifting EBITDA margin 150bps YoY to 21.5%.
- Network occupancy improved to 50.3% in Q2 and H1 occupancy rose to 47.9% from 44.7% YoY, indicating better capacity utilisation including the newly operationalised Raipur facility.
- ARPOB increased 7.1% YoY to ₹40,721 in Q2, while management reported H1 ARPOB growth of 8.1% to ₹41,490, supported by improved realisations and a stronger specialty mix.
- PAT increased 45.2% YoY to ₹15.4 crore and 21.0% QoQ, while H1 PAT rose 53.9% YoY to ₹28.1 crore.
Research and educational content only. Not investment advice.